7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/17/2013

Company Name Symbol %Change
VIASAT INC VSAT
19.35%
OLD SECOND B OSBC
5.76%
GAMCO INVEST GBL
4.61%
CORNING GLW
4.47%
SYNCHRONOSS SNCR
4.23%

TMK Grows Annually, Pares Guidance

by Zacks Equity Research

July 27, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Torchmark Corp. ( TMK - Analyst Report ) reported second-quarter 2012 net operating income of $1.30 per share, up 19.3% year over year. The increase can be attributed to higher insurance underwriting income coupled with increased investment income. Lower share count compared with the year-ago period, owing to share repurchases, also buoyed the bottom line.

Total insurance premium increased 6.0% year over year to $706.1 million, led by higher premium from the Life Insurance and Medicare Part D business, partly offset by lower premium from the Health Insurance business.

Net investment income increased 2% year over year to $180.7 million on the back of higher invested assets. However, excess investment income, a measure of the segment’s profitability, went down 5% to $62.5 million.

Underwriting income increased 8.0% year over year to $134.2 million, backed by higher margins at Life and Medicare Part D, partially offset by a lower margin in the Health business.

Segment Update

At Life Insurance operations, premium revenue increased 4% year over year to $451.0 million, led by higher premiums written by distribution channels – American Income Agency up 9% and Direct Response up 5% – partly offset by a 2% decrease in premiums written by Liberty National Life Agency. Life underwriting margins increased 7% to $124.2 million.

Health Insurance premium revenue declined 5% year over year to $176.9 million, while underwriting margin was down 2% to $40.3 million.

Premium revenue from the Medicare part D business increased 60% year over year to $78.1 million, while underwriting margin increased 47% to $8.2 million. This huge growth in Part D business came on the back of the company’s new lower cost part D plan for 2012, which significantly increased the number of low-income auto-enrollees. The product also enabled the company to increase its individual sales.

Return on equity (ROE) was 15.7% for the quarter, compared with 14.4% in the year-ago quarter.

During the quarter, Torchmark repurchased 3.9 million shares at a total cost of $184 million.

Looking Ahead

Management announced fiscal 2012 guidance for earnings per share in the range of $5.08 – $5.26. This marked a reduction from the earlier projected range of $5.10 – $5.40 per share.

Peer Assurant Inc. ( AIZ - Analyst Report ) also reported earnings on the same day, substantially ahead of the Zacks Consensus Estimate.

Torchmark currently retains a Zacks # 3 Rank, which translates into a short-term ‘Hold’ rating. We are also maintaining our long-term “Neutral” recommendation on its shares.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.